Logo image of VRNT

VERINT SYSTEMS INC (VRNT) Stock Fundamental Analysis

USA - NASDAQ:VRNT - US92343X1000 - Common Stock

20.32 USD
+0.01 (+0.05%)
Last: 9/16/2025, 8:00:02 PM
20.28 USD
-0.04 (-0.2%)
Pre-Market: 9/17/2025, 8:00:02 AM
Fundamental Rating

6

Taking everything into account, VRNT scores 6 out of 10 in our fundamental rating. VRNT was compared to 280 industry peers in the Software industry. While VRNT has a great profitability rating, there are some minor concerns on its financial health. VRNT scores decently on growth, while it is valued quite cheap. This could make an interesting combination. This makes VRNT very considerable for value investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

VRNT had positive earnings in the past year.
VRNT had a positive operating cash flow in the past year.
In multiple years VRNT reported negative net income over the last 5 years.
VRNT had a positive operating cash flow in each of the past 5 years.
VRNT Yearly Net Income VS EBIT VS OCF VS FCFVRNT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M 200M 250M

1.2 Ratios

VRNT's Return On Assets of 2.04% is fine compared to the rest of the industry. VRNT outperforms 65.00% of its industry peers.
With a decent Return On Equity value of 3.41%, VRNT is doing good in the industry, outperforming 66.43% of the companies in the same industry.
The Return On Invested Capital of VRNT (4.02%) is better than 71.79% of its industry peers.
The Average Return On Invested Capital over the past 3 years for VRNT is significantly below the industry average of 11.85%.
The 3 year average ROIC (3.56%) for VRNT is below the current ROIC(4.02%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.04%
ROE 3.41%
ROIC 4.02%
ROA(3y)1.13%
ROA(5y)0.55%
ROE(3y)1.95%
ROE(5y)0.91%
ROIC(3y)3.56%
ROIC(5y)2.96%
VRNT Yearly ROA, ROE, ROICVRNT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2 -2 4

1.3 Margins

Looking at the Profit Margin, with a value of 5.08%, VRNT is in the better half of the industry, outperforming 67.86% of the companies in the same industry.
VRNT's Profit Margin has improved in the last couple of years.
VRNT has a Operating Margin of 8.80%. This is in the better half of the industry: VRNT outperforms 73.57% of its industry peers.
VRNT's Operating Margin has improved in the last couple of years.
VRNT has a Gross Margin (69.91%) which is in line with its industry peers.
VRNT's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 8.8%
PM (TTM) 5.08%
GM 69.91%
OM growth 3Y27.59%
OM growth 5Y97.41%
PM growth 3YN/A
PM growth 5Y16.09%
GM growth 3Y2.67%
GM growth 5Y2.15%
VRNT Yearly Profit, Operating, Gross MarginsVRNT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so VRNT is destroying value.
Compared to 1 year ago, VRNT has less shares outstanding
Compared to 5 years ago, VRNT has less shares outstanding
Compared to 1 year ago, VRNT has an improved debt to assets ratio.
VRNT Yearly Shares OutstandingVRNT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
VRNT Yearly Total Debt VS Total AssetsVRNT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.2 Solvency

Based on the Altman-Z score of 1.22, we must say that VRNT is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of VRNT (1.22) is worse than 63.57% of its industry peers.
VRNT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 3.67
Altman-Z 1.22
ROIC/WACC0.41
WACC9.88%
VRNT Yearly LT Debt VS Equity VS FCFVRNT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B

2.3 Liquidity

VRNT has a Current Ratio of 0.65. This is a bad value and indicates that VRNT is not financially healthy enough and could expect problems in meeting its short term obligations.
VRNT has a worse Current ratio (0.65) than 86.43% of its industry peers.
VRNT has a Quick Ratio of 0.65. This is a bad value and indicates that VRNT is not financially healthy enough and could expect problems in meeting its short term obligations.
VRNT has a Quick ratio of 0.63. This is amonst the worse of the industry: VRNT underperforms 86.43% of its industry peers.
Industry RankSector Rank
Current Ratio 0.65
Quick Ratio 0.63
VRNT Yearly Current Assets VS Current LiabilitesVRNT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

4

3. Growth

3.1 Past

The earnings per share for VRNT have decreased strongly by -23.21% in the last year.
The Earnings Per Share has been decreasing by -6.23% on average over the past years.
Looking at the last year, VRNT shows a decrease in Revenue. The Revenue has decreased by -2.32% in the last year.
VRNT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.44% yearly.
EPS 1Y (TTM)-23.21%
EPS 3Y4.61%
EPS 5Y-6.23%
EPS Q2Q%-32.65%
Revenue 1Y (TTM)-2.32%
Revenue growth 3Y1.31%
Revenue growth 5Y1.44%
Sales Q2Q%-1.03%

3.2 Future

VRNT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.80% yearly.
Based on estimates for the next years, VRNT will show a small growth in Revenue. The Revenue will grow by 6.08% on average per year.
EPS Next Y14.43%
EPS Next 2Y11.94%
EPS Next 3Y11.48%
EPS Next 5Y11.8%
Revenue Next Year2.95%
Revenue Next 2Y4.3%
Revenue Next 3Y4.48%
Revenue Next 5Y6.08%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
VRNT Yearly Revenue VS EstimatesVRNT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
VRNT Yearly EPS VS EstimatesVRNT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3 4

9

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 9.45, the valuation of VRNT can be described as very reasonable.
Based on the Price/Earnings ratio, VRNT is valued cheaper than 90.36% of the companies in the same industry.
VRNT's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.20.
A Price/Forward Earnings ratio of 6.21 indicates a rather cheap valuation of VRNT.
96.79% of the companies in the same industry are more expensive than VRNT, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of VRNT to the average of the S&P500 Index (22.71), we can say VRNT is valued rather cheaply.
Industry RankSector Rank
PE 9.45
Fwd PE 6.21
VRNT Price Earnings VS Forward Price EarningsVRNT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, VRNT is valued cheaply inside the industry as 89.64% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of VRNT indicates a rather cheap valuation: VRNT is cheaper than 94.29% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 10.88
EV/EBITDA 11.35
VRNT Per share dataVRNT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

VRNT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of VRNT may justify a higher PE ratio.
PEG (NY)0.66
PEG (5Y)N/A
EPS Next 2Y11.94%
EPS Next 3Y11.48%

0

5. Dividend

5.1 Amount

No dividends for VRNT!.
Industry RankSector Rank
Dividend Yield N/A

VERINT SYSTEMS INC

NASDAQ:VRNT (9/16/2025, 8:00:02 PM)

Premarket: 20.28 -0.04 (-0.2%)

20.32

+0.01 (+0.05%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)09-02 2025-09-02/amc
Earnings (Next)12-02 2025-12-02/amc
Inst Owners112.08%
Inst Owner Change-3.58%
Ins Owners1.31%
Ins Owner Change13%
Market Cap1.23B
Analysts72.86
Price Target23.95 (17.86%)
Short Float %8.07%
Short Ratio2.51
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.32
Dividend Growth(5Y)N/A
DP35.22%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)25.67%
Min EPS beat(2)23.69%
Max EPS beat(2)27.66%
EPS beat(4)3
Avg EPS beat(4)12.63%
Min EPS beat(4)-23.66%
Max EPS beat(4)27.66%
EPS beat(8)6
Avg EPS beat(8)8.42%
EPS beat(12)9
Avg EPS beat(12)6.45%
EPS beat(16)13
Avg EPS beat(16)7.28%
Revenue beat(2)2
Avg Revenue beat(2)3.26%
Min Revenue beat(2)1.7%
Max Revenue beat(2)4.81%
Revenue beat(4)3
Avg Revenue beat(4)0.21%
Min Revenue beat(4)-10.26%
Max Revenue beat(4)4.81%
Revenue beat(8)4
Avg Revenue beat(8)-0.39%
Revenue beat(12)4
Avg Revenue beat(12)-1.39%
Revenue beat(16)5
Avg Revenue beat(16)-1.27%
PT rev (1m)-20.86%
PT rev (3m)-14.09%
EPS NQ rev (1m)-2.48%
EPS NQ rev (3m)-2.65%
EPS NY rev (1m)-0.05%
EPS NY rev (3m)-0.49%
Revenue NQ rev (1m)-0.15%
Revenue NQ rev (3m)-0.26%
Revenue NY rev (1m)-0.01%
Revenue NY rev (3m)0.11%
Valuation
Industry RankSector Rank
PE 9.45
Fwd PE 6.21
P/S 1.37
P/FCF 10.88
P/OCF 8.86
P/B 0.92
P/tB N/A
EV/EBITDA 11.35
EPS(TTM)2.15
EY10.58%
EPS(NY)3.27
Fwd EY16.1%
FCF(TTM)1.87
FCFY9.19%
OCF(TTM)2.29
OCFY11.29%
SpS14.82
BVpS22.1
TBVpS-2.51
PEG (NY)0.66
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.04%
ROE 3.41%
ROCE 5.39%
ROIC 4.02%
ROICexc 4.57%
ROICexgc N/A
OM 8.8%
PM (TTM) 5.08%
GM 69.91%
FCFM 12.6%
ROA(3y)1.13%
ROA(5y)0.55%
ROE(3y)1.95%
ROE(5y)0.91%
ROIC(3y)3.56%
ROIC(5y)2.96%
ROICexc(3y)4.12%
ROICexc(5y)3.6%
ROICexgc(3y)78.15%
ROICexgc(5y)N/A
ROCE(3y)4.77%
ROCE(5y)3.96%
ROICexcg growth 3Y0.75%
ROICexcg growth 5Y160.59%
ROICexc growth 3Y28.35%
ROICexc growth 5Y108.76%
OM growth 3Y27.59%
OM growth 5Y97.41%
PM growth 3YN/A
PM growth 5Y16.09%
GM growth 3Y2.67%
GM growth 5Y2.15%
F-Score6
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 3.67
Debt/EBITDA 0
Cap/Depr 51.05%
Cap/Sales 2.87%
Interest Coverage 11.19
Cash Conversion 107.26%
Profit Quality 247.96%
Current Ratio 0.65
Quick Ratio 0.63
Altman-Z 1.22
F-Score6
WACC9.88%
ROIC/WACC0.41
Cap/Depr(3y)48.9%
Cap/Depr(5y)43.87%
Cap/Sales(3y)3.26%
Cap/Sales(5y)3.49%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-23.21%
EPS 3Y4.61%
EPS 5Y-6.23%
EPS Q2Q%-32.65%
EPS Next Y14.43%
EPS Next 2Y11.94%
EPS Next 3Y11.48%
EPS Next 5Y11.8%
Revenue 1Y (TTM)-2.32%
Revenue growth 3Y1.31%
Revenue growth 5Y1.44%
Sales Q2Q%-1.03%
Revenue Next Year2.95%
Revenue Next 2Y4.3%
Revenue Next 3Y4.48%
Revenue Next 5Y6.08%
EBIT growth 1Y-25.15%
EBIT growth 3Y29.26%
EBIT growth 5Y100.25%
EBIT Next Year6.95%
EBIT Next 3Y5.75%
EBIT Next 5Y7.32%
FCF growth 1Y-7.67%
FCF growth 3Y8.71%
FCF growth 5Y-6.89%
OCF growth 1Y-11.57%
OCF growth 3Y7.82%
OCF growth 5Y-7.92%